Synthesis of C4-functionalized 1,2,3,4-tetrahydroacridine-based Pfitzinger acid derivatives in deep eutectic solvents and their biological evaluation as dual cholinesterase and α-glucosidase inhibitors†
Thangellapally Shirisha, Subir Majhi, Kalivarathan Divakar and Dhurke Kashinath
{"title":"Synthesis of C4-functionalized 1,2,3,4-tetrahydroacridine-based Pfitzinger acid derivatives in deep eutectic solvents and their biological evaluation as dual cholinesterase and α-glucosidase inhibitors†","authors":"Thangellapally Shirisha, Subir Majhi, Kalivarathan Divakar and Dhurke Kashinath","doi":"10.1039/D4NJ04137B","DOIUrl":null,"url":null,"abstract":"<p >Herein, we report an efficient strategy for the synthesis of C4-functionalized novel Pfitzinger acid derivatives <em>via</em> C(sp<small><sup>3</sup></small>)–H bond functionalization. This approach capitalizes on the use of a deep eutectic solvent (DES) comprising <em>N</em>,<em>N</em>′-dimethyl urea and <small>L</small>-(+)-tartaric acid (3 : 1 ratio) at 80 °C as the reaction medium. The 1,2,3,4-tetrahydroacridine-based Pfitzinger acid and its derivatives (methyl/benzyl esters, amides, and Weinreb amides) were used for C4 functionalization with aromatic aldehydes. All the synthesized compounds were evaluated for their dual cholinesterase and α-glucosidase inhibitory activity. Most of the evaluated products showed significant inhibitory activity against AChE, BChE and α-glucosidase enzymes in comparison with standard drug tacrine (AChE IC<small><sub>50</sub></small> = 201.05 nM; BChE IC<small><sub>50</sub></small> = 202.14 nM) and acarbose (IC<small><sub>50</sub></small> = 23 124 nM). Among the tested compounds, <strong>6f</strong> showed inhibitory activity with IC<small><sub>50</sub></small> = 119.45 nM (for AChE) and IC<small><sub>50</sub></small> = 121.58 nM (for BChE), <strong>6v</strong> showed inhibitory activity with IC<small><sub>50</sub></small> = 121.87 nM (for AChE) and IC<small><sub>50</sub></small> = 118.25 nM (for BChE) and <strong>9g</strong> inhibitory activity against α-glucosidase with IC<small><sub>50</sub></small> = 21 442 nM. The docking and kinetic studies supported the experimental results obtained through <em>in vitro</em> experiments and predicted drug-like properties.</p>","PeriodicalId":95,"journal":{"name":"New Journal of Chemistry","volume":" 3","pages":" 1072-1082"},"PeriodicalIF":2.7000,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"New Journal of Chemistry","FirstCategoryId":"92","ListUrlMain":"https://pubs.rsc.org/en/content/articlelanding/2025/nj/d4nj04137b","RegionNum":3,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
引用次数: 0
Abstract
Herein, we report an efficient strategy for the synthesis of C4-functionalized novel Pfitzinger acid derivatives via C(sp3)–H bond functionalization. This approach capitalizes on the use of a deep eutectic solvent (DES) comprising N,N′-dimethyl urea and L-(+)-tartaric acid (3 : 1 ratio) at 80 °C as the reaction medium. The 1,2,3,4-tetrahydroacridine-based Pfitzinger acid and its derivatives (methyl/benzyl esters, amides, and Weinreb amides) were used for C4 functionalization with aromatic aldehydes. All the synthesized compounds were evaluated for their dual cholinesterase and α-glucosidase inhibitory activity. Most of the evaluated products showed significant inhibitory activity against AChE, BChE and α-glucosidase enzymes in comparison with standard drug tacrine (AChE IC50 = 201.05 nM; BChE IC50 = 202.14 nM) and acarbose (IC50 = 23 124 nM). Among the tested compounds, 6f showed inhibitory activity with IC50 = 119.45 nM (for AChE) and IC50 = 121.58 nM (for BChE), 6v showed inhibitory activity with IC50 = 121.87 nM (for AChE) and IC50 = 118.25 nM (for BChE) and 9g inhibitory activity against α-glucosidase with IC50 = 21 442 nM. The docking and kinetic studies supported the experimental results obtained through in vitro experiments and predicted drug-like properties.